Novartis AG
Nucleic acids and proteins from streptococcus groups A and B

Last updated:

Abstract:

The invention provides proteins from group B streptococcus (Streptococcus agalactiae) and group A streptococcus (Streptococcus pyogenes), including amino acid sequences and the corresponding nucleotide sequences. Data are given to show that the proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics. The proteins are also targets for antibiotics.

Status:
Grant
Type:

Utility

Filling date:

7 Nov 2017

Issue date:

1 Oct 2019